Filing Details

Accession Number:
0001127602-20-021761
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-17 17:34:20
Reporting Period:
2020-07-15
Accepted Time:
2020-07-17 17:34:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1619929 G Elizabeth Nabel C/O Moderna, Inc.
200 Technology Square
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-15 40,307 $14.22 54,651 No 4 M Direct
Common Stock Acquisiton 2020-07-15 8,376 $19.15 63,027 No 4 M Direct
Common Stock Acquisiton 2020-07-15 10,948 $19.15 73,975 No 4 M Direct
Common Stock Disposition 2020-07-15 73,975 $87.84 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-07-15 40,307 $0.00 40,307 $14.22
Common Stock Stock Option (Right to Buy) Disposition 2020-07-15 8,376 $0.00 8,376 $19.15
Common Stock Stock Option (Right to Buy) Disposition 2020-07-15 10,948 $0.00 10,948 $19.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2028-02-28 No 4 M Direct
0 2026-08-10 No 4 M Direct
0 2026-08-10 No 4 M Direct
Footnotes
  1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2020.
  2. This option will become fully vested and exercisable on February 28, 2019.
  3. This option is fully vested and exercisable.